Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories has informed BSE about a Board meeting on May 30, 2025. The Board will consider and approve the audited standalone financial results for the quarter and full financial year ended March 31, 2025. It will also consider recommending a final dividend on equity shares for FY2024-25. Additionally, the Board will appoint Secretarial Auditor (for 5 years from FY2025-26), Internal Auditor for FY2025-26, and Cost Auditor for FY2025-26. The trading window for dealing in the company's shares has been closed since April 1, 2025, and will reopen 48 hours after the results are announced.
This is a routine pre-results intimation. Investors should watch for the Q4 and FY25 earnings announcement on May 30, along with any declared final dividend, which could influence short-term price action.